The South Korean platelet rich plasma market is set for substantial growth over the next decade, with a projected compound annual growth rate (CAGR) of 8% from 2024 to 2034. This trajectory mirrors the expansion of the global PRP market, which is expected to surge from USD 444.4 million in 2024 to an impressive USD 1,163.1 million by 2034, reflecting a CAGR of 10.1%.